Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: Role of decreased intracellular TNF-

Clinical Immunology and Immunopathology

Volumn 81, Issue 3, 1996, Pages 293-302

  Kovacs, Birgit ^a   Vassilopoulos, Dimitrios ^a   Vogelgesang, Scott A ^b   Tsokos, George C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION;

EID: 0030560974     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0192     Document Type: Article

References (43)

1. 1. Cohen, J. J., Apoptosis. Immunol. Today 14, 126-130, 1993.
2. 2. Cohen, J. J., Programmed cell death and apoptosis in lymphocyte development and function. Chest 103, 99S-101S, 1993.
3. 3. Krammer, P. H., Behrmann, I., Daniel, P., Dhein, J., and Debatin, K. M., Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6, 279-289, 1994.
4. 4. Wu, J., Zhou, T., He, J., and Mountz, J. D., Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178, 461-468, 1993.
5. 5. Ramsdell, F., Seaman, M. S., Miller, R. E., Tough, T. W., Alderson, M. R., and Lynch, D. H., gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24, 928-933, 1994.
6. 6. Ettinger, R., Wang, J. K., Bossu, P., Papas, K., Sidman, C. L., Abbas, A. K., and Marshak-Rothstein, A., Functional distinctions between MRL-1pr and MRL-gld lymphocytes: Normal cells reverse the gld but not lpr immunoregulatory defect. J. Immunol. 152, 1557-1568, 1994.
7. 7. Green, D. R., and Scott, D. W., Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol. 6, 476-487, 1994.
8. 8. Kabelitz, D., Pohl, T., and Pechhold, K., Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today 14, 338-339, 1993.
9. 9. Wesselborg, S., Janssen, O., and Kabelitz, D., Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150, 4338-4345, 1993.
10. 10. Radvanyi, L. G., Mills, G. B., and Miller, R. G., Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J. Immunol. 150, 5704-5715, 1993.
11. 11. Klas, C., Debatin, K. M., Jonker, R. R., and Krammer, P. H., Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5, 625-630, 1993.
12. 12. Vignaux, F., and Golstein, P., Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: A regulatory pathway? Eur. J. Immunol. 24, 923-927, 1994.
13. 13. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C.A., Ramsdell, F., and Lynch, D. H., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181, 71-77, 1995.
14. 14. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothstein, A., Fas(CD95)/ FasL interactions required for programmed cell death after T cell activation [see comments]. Nature 373, 444-448, 1995.
15. 15. Dhein, J., Walczak, H., Baeumler, C., Debatin, K. M., and Krammer, P. H., Autocrine T cell suicide mediated by APO-1/(Fas/ CD95). Nature 373, 438-441, 1995.
16. 16. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F. S., and Martin, Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444, 1995.
17. 17. Tsokos, G. C., Overview of cellular immune function in systemic lupus erythematosus. In "Systemic Lupus Erythematosus" (R. G. LaHita, Ed.), pp. 13-48, Churchill Livingstone, New York, 1995.
18. 18. Emlen, W., Niebur, J., and Kadera, R., Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152, 3685-3692, 1994.
19. 19. Mysler, E., Bini, P., Drappa, J., Ramos, P., Friedman, S. M., Krammer, P. H., and Elkon, K. B., The apoptosis-1/Fas protein in human systemic lupus erythematosus. J. Clin. Invest. 93, 1029-1034, 1994.
20. 20. Aringer, M., Wintersberger, W., Steiner, C. W., Kiener, H., Presterl, E., Jaeger, U., Smolen, J. S., and Graninger, W. B., High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum. 37, 1423-1430, 1994.
21. 21. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., and Mountz, J. D., Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759-1762, 1994.
22. 22. Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., and Winchester, R. J., The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271, 1982.
23. 23. Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., and Chang, C. H., Derivation of the SLEDAI: A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35, 630-640, 1992.
24. 24. Kovacs, B., and Tsokos, G. C., Cross-linking of the Fas/APO-1 antigen suppresses the CD3-mediated signal transduction events in human T lymphocytes. J. Immunol. 155, 5543-5549, 1995.
25. 25. Yonehara, S., Ishii, A., and Yonehara, M., A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necosis factor. J. Exp. Med. 169, 1747-1756, 1989.
26. 26. Yonehare, S., Nishimura, Y., Kishil, S., Yonehara, M., Takazawa, K., Tamatani, T., and Ishii, A., Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int. Immunol. 6, 1849-1856, 1994.
27. 27. Nicoletti, I., Migliorati, C., Paglacci, M., Grignani, F., and Riccardi, C., A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 134, 271-279, 1991.
28. 28. Tucek-Szabo, C. L., Andjelic, S., Lacy, E., Elkon, K. B., and Nikolic-Zugic, J., Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis: Activation-induced death can occur without Fas receptor. J. Immunol. 156, 192-200, 1996.
29. 29. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H., and Lenardo, M. J., Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348-351, 1995.
30. 30. Wang, J., Stohlman, S. A., and Dennert, G., TCR cross-linking induces CTL death via internal action of TNF. J. Immunol. 152, 3824-3832, 1994.
31. 31. Jacob, C. O., and McDevitt, H. O., Tumor necrosis factor-alpha in murine autoimmune "lupus" nephritis. Nature 331, 356-358, 1988.
32. 32. Jacob, C. O., Fronek, Z., Lewis, G. D., Koo, M., Hansen, J. A., and McDevitt, H. O., Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: Relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 87, 1233-1237, 1990.
33. 33. Inghirami, G., Simon, J., Balow, J. E., and Tsokos, G. C., Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin. Clin. Exp. Rheumatol. 6, 269-276, 1988.
34. + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 143, 103-112, 1989.
35. 35. Mountz, J. D., Wu, J., Cheng, J., and Zhou, T., Autoimmune disease: A problem of defective apoptosis. Arthritis Rheum. 37, 1415-1420, 1994.
36. 36. Nagata, S., and Suda, T., Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16 (1), 39-43, 1995.
37. 37. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976, 1994.
38. 38. Ohsako, S., Hara, M., Harigai, M., Fukasawa, C., and Kashiwazaki, S., Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin. Immunol. Immunopathol. 73, 109-114, 1994.
39. 39. Richardson, B. C., Yung, R. L., Johnson, K. J., Rowse, P. E., and Lalwani, N. D., Monocyte apoptosis in patients with active lupus. Arthritis Rheum. 39, 1432-1434, 1996.
40. 40. Amasaki, Y., Kobayashi, S., Takeda, T., Ogura, N., Jodo, S., Nakabayashi, T., Tsutsumi, A., Fujisaku, A., and Koike, T., Upregulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): A possible mechanism for lymphopenia. Clin. Exp. Immunol. 99, 245-250, 1995.
41. 41. Mohan, C., Adams, S., Stanik, V., and Datta, S. K., Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177, 1367-1381, 1993.
42. 42. Casciola-Rosen, L., Rosen, A., Petri, M., and Schliessel, M., Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 93, 1624-1629, 1996.
43. 43. McNally, J., Drappa, J., Friedman, S. M., and Elkon, K B., Expression of the Fas ligand in SLE. Arthritis Rheum. 38, S210, 1995. [Abstract]